Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.6.0 to v3.6.2, signaling a minor site release. There are no changes to study details or user-facing content reflected in this update.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study page adds a recruitment status of no longer looking for participants and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a revision update (Revision: v3.6.0) and adjusts the Intervention/Treatment header, while the older header (Intervention / Treatment) and previous revision note (v3.5.5) are removed.SummaryDifference0.4%

- Check22 days agoChange DetectedThe page now displays a new site revision (v3.5.5), replacing the previous revision (v3.5.4). This indicates an underlying platform update rather than a modification to the study data.SummaryDifference0.1%

- Check36 days agoChange DetectedNo textual changes are detected for the study page based on the provided data. The page content appears unchanged relative to the last recorded version.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays a revision tag of v3.5.4, replacing the previous v3.5.3 and signaling an updated page version.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page footer revision tag was updated from v3.5.2 to v3.5.3, signaling a minor site update to the template.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.